Drug development is a long and tedious process, often taking years to reach commercialisation. Small-cap biotech company Orthocell Ltd [ASX:OCC] knows this all too well, having spent years bringing their tissue repair…
When it comes to biotech stocks, the ultimate goal is always to get a drug to market. Acrux today shared the good news that their testosterone topic solution has been approved by the US Food & Drug Administration (FDA)…
As you’ll see, the investment performance of nearly all of the investment services was outstanding, given the volatility experienced throughout the year. It’s a performance we’ll be working hard to…
Imugene Ltd [ASX:IMU] certainly finished 2020 with a bang. With a 5% lift in the IMU share price this morning, the stock is making waves once more. Today, it has since eased back from those record highs, but it is still faring well…
At time of writing the share price of Rhythm Biosciences Ltd [ASX:RHY] is trading at $1.37, up 5.79%. Rhythm Biosciences experienced explosive growth in its share price throughout 2020, moving up over 3,720%.
The Mesoblast Ltd [ASX:MSB] share price has been absolutely hammered today, trading 32.63% lower at time of writing. The result comes as the company shared some disheartening news. The trial of its remestemcel-L therapy…
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988
